A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson’s disease (the ADAGIO study): rationale, design, and baseline characteristics - Olanow, CW; Hauser, RA; Jankovic, J; Langston, W; Lang, A; Poewe, W (Mov Disord, 2008)
et al